DMAC · Forms 3, 4, 5

Insider trades at DiaMedica Therapeutics Inc.

No open-market insider buys or sells at DiaMedica Therapeutics Inc. in the last 90 days; 1 filing reported awards, option exercises, tax withholding or new insiders.

Every Form 3, 4 and 5 filed for DiaMedica Therapeutics Inc. (DMAC) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Dietrich John PaulsPresident & CEOAward60,200Form 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.